mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-07 |
mRNA |
necrosulfonamide |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
3e-07 |
mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
3e-07 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
3e-07 |
mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
-0.17 |
6e-07 |
mRNA |
KPT185 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
6e-07 |
mRNA |
NVP-BEZ235 |
GDSC1000 |
pan-cancer |
AAC |
-0.19 |
6e-07 |
mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
1e-06 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-06 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-06 |